FDA Inspection 1114622 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on December 20, 2019 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 20, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cleveland, OH (United States)